Biodesix to present at the canaccord genuity virtual medtech, diagnostics and digital health & services forum

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced scott hutton, chief executive officer of biodesix, will present in a fireside chat at the canaccord genuity virtual medtech, diagnostics and digital health & services forum being held virtually november 18, 2021. canaccord genuity virtual medtech, diagnostics and digital health & services forum date: thursday, november 18, 2021
BDSX Ratings Summary
BDSX Quant Ranking